HEADER TRANSCRIPTION/DNA 02-JUN-13 4L18 TITLE CRYSTAL STRUCTURE OF RUNX1 AND ETS1 BOUND TO TCR ALPHA PROMOTER TITLE 2 (CRYSTAL FORM 3) COMPND MOL_ID: 1; COMPND 2 MOLECULE: RUNT-RELATED TRANSCRIPTION FACTOR 1; COMPND 3 CHAIN: A, E; COMPND 4 FRAGMENT: UNP RESIDUES 48-214; COMPND 5 SYNONYM: RUNX1, ACUTE MYELOID LEUKEMIA 1 PROTEIN, CORE-BINDING FACTOR COMPND 6 SUBUNIT ALPHA-2, CBF-ALPHA-2, ONCOGENE AML-1, POLYOMAVIRUS ENHANCER- COMPND 7 BINDING PROTEIN 2 ALPHA B SUBUNIT, PEA2-ALPHA B, PEBP2-ALPHA B, SL3-3 COMPND 8 ENHANCER FACTOR 1 ALPHA B SUBUNIT, SL3/AKV CORE-BINDING FACTOR ALPHA COMPND 9 B SUBUNIT; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 2; COMPND 12 MOLECULE: PROTEIN C-ETS-1; COMPND 13 CHAIN: B, F; COMPND 14 FRAGMENT: UNP RESIDUES 296-441; COMPND 15 SYNONYM: ETS1, P54; COMPND 16 ENGINEERED: YES; COMPND 17 MOL_ID: 3; COMPND 18 MOLECULE: 5'-D(*GP*GP*AP*AP*GP*CP*CP*AP*CP*AP*TP*CP*CP*TP*CP*T)-3'; COMPND 19 CHAIN: C, G; COMPND 20 ENGINEERED: YES; COMPND 21 OTHER_DETAILS: TCR ALPHA DNA STRAND 1; COMPND 22 MOL_ID: 4; COMPND 23 MOLECULE: 5'-D(*CP*AP*GP*AP*GP*GP*AP*TP*GP*TP*GP*GP*CP*TP*TP*C)-3'; COMPND 24 CHAIN: D, H; COMPND 25 ENGINEERED: YES; COMPND 26 OTHER_DETAILS: TCR ALPHA DNA STRAND 2 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: RUNX1, AML1, CBFA2, PEBP2AB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: ETS1, EWSR2; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 15 MOL_ID: 3; SOURCE 16 SYNTHETIC: YES; SOURCE 17 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 18 ORGANISM_COMMON: HUMAN; SOURCE 19 ORGANISM_TAXID: 9606; SOURCE 20 MOL_ID: 4; SOURCE 21 SYNTHETIC: YES; SOURCE 22 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 23 ORGANISM_COMMON: HUMAN; SOURCE 24 ORGANISM_TAXID: 9606 KEYWDS RUNT DOMAIN, ETS DOMAIN, TRANSCRIPTION-DNA COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.H.TAHIROV REVDAT 4 28-FEB-24 4L18 1 REMARK REVDAT 3 22-OCT-14 4L18 1 JRNL REVDAT 2 02-APR-14 4L18 1 JRNL REVDAT 1 26-MAR-14 4L18 0 JRNL AUTH T.SHRIVASTAVA,K.MINO,N.D.BABAYEVA,O.I.BARANOVSKAYA, JRNL AUTH 2 A.RIZZINO,T.H.TAHIROV JRNL TITL STRUCTURAL BASIS OF ETS1 ACTIVATION BY RUNX1. JRNL REF LEUKEMIA V. 28 2040 2014 JRNL REFN ISSN 0887-6924 JRNL PMID 24646888 JRNL DOI 10.1038/LEU.2014.111 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.64 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1680438.940 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 87.5 REMARK 3 NUMBER OF REFLECTIONS : 33721 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.231 REMARK 3 FREE R VALUE : 0.280 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1665 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.44 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 50.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3167 REMARK 3 BIN R VALUE (WORKING SET) : 0.4870 REMARK 3 BIN FREE R VALUE : 0.4450 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 154 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.036 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3982 REMARK 3 NUCLEIC ACID ATOMS : 1300 REMARK 3 HETEROGEN ATOMS : 6 REMARK 3 SOLVENT ATOMS : 143 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 49.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.22000 REMARK 3 B22 (A**2) : 1.00000 REMARK 3 B33 (A**2) : 0.22000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.92000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.44 REMARK 3 ESD FROM SIGMAA (A) : 0.60 REMARK 3 LOW RESOLUTION CUTOFF (A) : 20.0 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.51 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.67 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.070 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 3.490 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 5.320 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 5.180 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 6.840 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 42.73 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : GOL.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : GOL.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4L18 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-JUN-13. REMARK 100 THE DEPOSITION ID IS D_1000080052. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JAN-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-E REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9 REMARK 200 MONOCHROMATOR : CRYOGENICALLY-COOLED SINGLE REMARK 200 CRYSTAL SI(220) SIDE BOUNCE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35376 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.4 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.05600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 26.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.34 REMARK 200 COMPLETENESS FOR SHELL (%) : 60.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : 0.39200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.96 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.5% W/V PEG4000, 5 MM MAGNESIUM REMARK 280 CHLORIDE HEXAHYDRATE, 25 MM MES, PH 5.6, 5% V/V GLYCEROL, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 50.01600 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17370 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -37.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5680 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17070 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -33.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 48 REMARK 465 ARG A 49 REMARK 465 SER A 50 REMARK 465 MET A 51 REMARK 465 VAL A 52 REMARK 465 ARG A 178 REMARK 465 HIS A 179 REMARK 465 ARG A 180 REMARK 465 GLN A 181 REMARK 465 LYS A 182 REMARK 465 LEU A 183 REMARK 465 ASP A 184 REMARK 465 ASP A 185 REMARK 465 GLN A 186 REMARK 465 THR A 187 REMARK 465 LYS A 188 REMARK 465 ARG A 206 REMARK 465 THR A 207 REMARK 465 ALA A 208 REMARK 465 MET A 209 REMARK 465 ARG A 210 REMARK 465 VAL A 211 REMARK 465 SER A 212 REMARK 465 PRO A 213 REMARK 465 HIS A 214 REMARK 465 PRO B 296 REMARK 465 ASN B 297 REMARK 465 HIS B 298 REMARK 465 LYS B 299 REMARK 465 PRO B 300 REMARK 465 LYS B 301 REMARK 465 GLY B 302 REMARK 465 THR B 303 REMARK 465 PHE B 304 REMARK 465 LYS B 305 REMARK 465 ASP B 306 REMARK 465 TYR B 307 REMARK 465 VAL B 308 REMARK 465 ARG B 309 REMARK 465 ASP B 310 REMARK 465 ARG B 311 REMARK 465 ALA B 312 REMARK 465 ASP B 313 REMARK 465 LEU B 314 REMARK 465 ASN B 315 REMARK 465 LYS B 316 REMARK 465 ASP B 317 REMARK 465 LYS B 318 REMARK 465 PRO B 319 REMARK 465 VAL B 320 REMARK 465 ILE B 321 REMARK 465 PRO B 322 REMARK 465 ALA B 323 REMARK 465 ALA B 324 REMARK 465 ALA B 325 REMARK 465 LEU B 326 REMARK 465 ALA B 327 REMARK 465 GLY B 328 REMARK 465 TYR B 329 REMARK 465 THR B 330 REMARK 465 GLY B 331 REMARK 465 SER B 332 REMARK 465 ASP B 440 REMARK 465 GLU B 441 REMARK 465 ASP E 48 REMARK 465 ARG E 49 REMARK 465 SER E 50 REMARK 465 MET E 51 REMARK 465 ARG E 178 REMARK 465 HIS E 179 REMARK 465 ARG E 180 REMARK 465 GLN E 181 REMARK 465 LYS E 182 REMARK 465 LEU E 183 REMARK 465 ASP E 184 REMARK 465 ASP E 185 REMARK 465 GLN E 186 REMARK 465 THR E 187 REMARK 465 LYS E 188 REMARK 465 PRO E 189 REMARK 465 ARG E 205 REMARK 465 ARG E 206 REMARK 465 THR E 207 REMARK 465 ALA E 208 REMARK 465 MET E 209 REMARK 465 ARG E 210 REMARK 465 VAL E 211 REMARK 465 SER E 212 REMARK 465 PRO E 213 REMARK 465 HIS E 214 REMARK 465 PRO F 296 REMARK 465 ASN F 297 REMARK 465 HIS F 298 REMARK 465 LYS F 299 REMARK 465 PRO F 300 REMARK 465 LYS F 301 REMARK 465 GLY F 302 REMARK 465 THR F 303 REMARK 465 PHE F 304 REMARK 465 LYS F 305 REMARK 465 ASP F 306 REMARK 465 TYR F 307 REMARK 465 VAL F 308 REMARK 465 ARG F 309 REMARK 465 ASP F 310 REMARK 465 ARG F 311 REMARK 465 ALA F 312 REMARK 465 ASP F 313 REMARK 465 LEU F 314 REMARK 465 ASN F 315 REMARK 465 LYS F 316 REMARK 465 ASP F 317 REMARK 465 LYS F 318 REMARK 465 PRO F 319 REMARK 465 VAL F 320 REMARK 465 ILE F 321 REMARK 465 PRO F 322 REMARK 465 ALA F 323 REMARK 465 ALA F 324 REMARK 465 ALA F 325 REMARK 465 LEU F 326 REMARK 465 ALA F 327 REMARK 465 GLY F 328 REMARK 465 TYR F 329 REMARK 465 THR F 330 REMARK 465 GLY F 331 REMARK 465 ASP F 438 REMARK 465 ALA F 439 REMARK 465 ASP F 440 REMARK 465 GLU F 441 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 DA C 8 O4' - C1' - N9 ANGL. DEV. = 2.2 DEGREES REMARK 500 DG D 103 O4' - C1' - N9 ANGL. DEV. = 2.2 DEGREES REMARK 500 LEU E 55 N - CA - C ANGL. DEV. = -18.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 109 -165.51 -173.86 REMARK 500 ALA A 120 23.50 -79.78 REMARK 500 GLN A 127 -0.31 68.20 REMARK 500 PHE A 153 55.09 -68.51 REMARK 500 LEU A 204 -80.62 -3.53 REMARK 500 GLN B 351 -8.57 -54.11 REMARK 500 ASN B 380 62.87 61.22 REMARK 500 ASN E 109 -162.16 -173.49 REMARK 500 PHE E 153 56.08 -67.58 REMARK 500 ARG E 164 55.75 38.40 REMARK 500 GLN F 351 -6.15 -57.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 DG C 5 0.08 SIDE CHAIN REMARK 500 DC C 13 0.06 SIDE CHAIN REMARK 500 DG D 103 0.06 SIDE CHAIN REMARK 500 DG G 205 0.06 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL D 201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4L0Y RELATED DB: PDB REMARK 900 RELATED ID: 4L0Z RELATED DB: PDB DBREF 4L18 A 48 214 UNP Q03347 RUNX1_MOUSE 48 214 DBREF 4L18 B 296 441 UNP P14921 ETS1_HUMAN 296 441 DBREF 4L18 E 48 214 UNP Q03347 RUNX1_MOUSE 48 214 DBREF 4L18 F 296 441 UNP P14921 ETS1_HUMAN 296 441 DBREF 4L18 C 1 16 PDB 4L18 4L18 1 16 DBREF 4L18 G 201 216 PDB 4L18 4L18 201 216 DBREF 4L18 D 101 116 PDB 4L18 4L18 101 116 DBREF 4L18 H 301 316 PDB 4L18 4L18 301 316 SEQRES 1 A 167 ASP ARG SER MET VAL GLU VAL LEU ALA ASP HIS PRO GLY SEQRES 2 A 167 GLU LEU VAL ARG THR ASP SER PRO ASN PHE LEU CYS SER SEQRES 3 A 167 VAL LEU PRO THR HIS TRP ARG CYS ASN LYS THR LEU PRO SEQRES 4 A 167 ILE ALA PHE LYS VAL VAL ALA LEU GLY ASP VAL PRO ASP SEQRES 5 A 167 GLY THR LEU VAL THR VAL MET ALA GLY ASN ASP GLU ASN SEQRES 6 A 167 TYR SER ALA GLU LEU ARG ASN ALA THR ALA ALA MET LYS SEQRES 7 A 167 ASN GLN VAL ALA ARG PHE ASN ASP LEU ARG PHE VAL GLY SEQRES 8 A 167 ARG SER GLY ARG GLY LYS SER PHE THR LEU THR ILE THR SEQRES 9 A 167 VAL PHE THR ASN PRO PRO GLN VAL ALA THR TYR HIS ARG SEQRES 10 A 167 ALA ILE LYS ILE THR VAL ASP GLY PRO ARG GLU PRO ARG SEQRES 11 A 167 ARG HIS ARG GLN LYS LEU ASP ASP GLN THR LYS PRO GLY SEQRES 12 A 167 SER LEU SER PHE SER GLU ARG LEU SER GLU LEU GLU GLN SEQRES 13 A 167 LEU ARG ARG THR ALA MET ARG VAL SER PRO HIS SEQRES 1 B 146 PRO ASN HIS LYS PRO LYS GLY THR PHE LYS ASP TYR VAL SEQRES 2 B 146 ARG ASP ARG ALA ASP LEU ASN LYS ASP LYS PRO VAL ILE SEQRES 3 B 146 PRO ALA ALA ALA LEU ALA GLY TYR THR GLY SER GLY PRO SEQRES 4 B 146 ILE GLN LEU TRP GLN PHE LEU LEU GLU LEU LEU THR ASP SEQRES 5 B 146 LYS SER CYS GLN SER PHE ILE SER TRP THR GLY ASP GLY SEQRES 6 B 146 TRP GLU PHE LYS LEU SER ASP PRO ASP GLU VAL ALA ARG SEQRES 7 B 146 ARG TRP GLY LYS ARG LYS ASN LYS PRO LYS MET ASN TYR SEQRES 8 B 146 GLU LYS LEU SER ARG GLY LEU ARG TYR TYR TYR ASP LYS SEQRES 9 B 146 ASN ILE ILE HIS LYS THR ALA GLY LYS ARG TYR VAL TYR SEQRES 10 B 146 ARG PHE VAL CYS ASP LEU GLN SER LEU LEU GLY TYR THR SEQRES 11 B 146 PRO GLU GLU LEU HIS ALA MET LEU ASP VAL LYS PRO ASP SEQRES 12 B 146 ALA ASP GLU SEQRES 1 C 16 DG DG DA DA DG DC DC DA DC DA DT DC DC SEQRES 2 C 16 DT DC DT SEQRES 1 D 16 DC DA DG DA DG DG DA DT DG DT DG DG DC SEQRES 2 D 16 DT DT DC SEQRES 1 E 167 ASP ARG SER MET VAL GLU VAL LEU ALA ASP HIS PRO GLY SEQRES 2 E 167 GLU LEU VAL ARG THR ASP SER PRO ASN PHE LEU CYS SER SEQRES 3 E 167 VAL LEU PRO THR HIS TRP ARG CYS ASN LYS THR LEU PRO SEQRES 4 E 167 ILE ALA PHE LYS VAL VAL ALA LEU GLY ASP VAL PRO ASP SEQRES 5 E 167 GLY THR LEU VAL THR VAL MET ALA GLY ASN ASP GLU ASN SEQRES 6 E 167 TYR SER ALA GLU LEU ARG ASN ALA THR ALA ALA MET LYS SEQRES 7 E 167 ASN GLN VAL ALA ARG PHE ASN ASP LEU ARG PHE VAL GLY SEQRES 8 E 167 ARG SER GLY ARG GLY LYS SER PHE THR LEU THR ILE THR SEQRES 9 E 167 VAL PHE THR ASN PRO PRO GLN VAL ALA THR TYR HIS ARG SEQRES 10 E 167 ALA ILE LYS ILE THR VAL ASP GLY PRO ARG GLU PRO ARG SEQRES 11 E 167 ARG HIS ARG GLN LYS LEU ASP ASP GLN THR LYS PRO GLY SEQRES 12 E 167 SER LEU SER PHE SER GLU ARG LEU SER GLU LEU GLU GLN SEQRES 13 E 167 LEU ARG ARG THR ALA MET ARG VAL SER PRO HIS SEQRES 1 F 146 PRO ASN HIS LYS PRO LYS GLY THR PHE LYS ASP TYR VAL SEQRES 2 F 146 ARG ASP ARG ALA ASP LEU ASN LYS ASP LYS PRO VAL ILE SEQRES 3 F 146 PRO ALA ALA ALA LEU ALA GLY TYR THR GLY SER GLY PRO SEQRES 4 F 146 ILE GLN LEU TRP GLN PHE LEU LEU GLU LEU LEU THR ASP SEQRES 5 F 146 LYS SER CYS GLN SER PHE ILE SER TRP THR GLY ASP GLY SEQRES 6 F 146 TRP GLU PHE LYS LEU SER ASP PRO ASP GLU VAL ALA ARG SEQRES 7 F 146 ARG TRP GLY LYS ARG LYS ASN LYS PRO LYS MET ASN TYR SEQRES 8 F 146 GLU LYS LEU SER ARG GLY LEU ARG TYR TYR TYR ASP LYS SEQRES 9 F 146 ASN ILE ILE HIS LYS THR ALA GLY LYS ARG TYR VAL TYR SEQRES 10 F 146 ARG PHE VAL CYS ASP LEU GLN SER LEU LEU GLY TYR THR SEQRES 11 F 146 PRO GLU GLU LEU HIS ALA MET LEU ASP VAL LYS PRO ASP SEQRES 12 F 146 ALA ASP GLU SEQRES 1 G 16 DG DG DA DA DG DC DC DA DC DA DT DC DC SEQRES 2 G 16 DT DC DT SEQRES 1 H 16 DC DA DG DA DG DG DA DT DG DT DG DG DC SEQRES 2 H 16 DT DT DC HET GOL D 201 6 HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 9 GOL C3 H8 O3 FORMUL 10 HOH *143(H2 O) HELIX 1 1 SER A 193 LEU A 204 1 12 HELIX 2 2 GLN B 336 LEU B 345 1 10 HELIX 3 3 THR B 346 GLN B 351 5 6 HELIX 4 4 ASP B 367 ASN B 380 1 14 HELIX 5 5 ASN B 385 LYS B 399 1 15 HELIX 6 6 ASP B 417 GLY B 423 1 7 HELIX 7 7 THR B 425 LEU B 433 1 9 HELIX 8 8 SER E 193 GLU E 202 1 10 HELIX 9 9 GLN F 336 THR F 346 1 11 HELIX 10 10 ASP F 347 GLN F 351 5 5 HELIX 11 11 ASP F 367 ASN F 380 1 14 HELIX 12 12 ASN F 385 LYS F 399 1 15 HELIX 13 13 ASP F 417 GLY F 423 1 7 HELIX 14 14 THR F 425 LEU F 433 1 9 SHEET 1 A 9 LEU A 62 ARG A 64 0 SHEET 2 A 9 PHE A 70 SER A 73 -1 O CYS A 72 N VAL A 63 SHEET 3 A 9 LYS A 90 ALA A 93 -1 O VAL A 92 N LEU A 71 SHEET 4 A 9 VAL A 128 ARG A 130 -1 O ALA A 129 N VAL A 91 SHEET 5 A 9 THR A 121 LYS A 125 -1 N LYS A 125 O VAL A 128 SHEET 6 A 9 LEU A 102 GLY A 108 -1 N VAL A 103 O ALA A 122 SHEET 7 A 9 PHE A 146 VAL A 152 -1 O THR A 147 N GLY A 108 SHEET 8 A 9 GLN A 158 THR A 169 -1 O ALA A 160 N ILE A 150 SHEET 9 A 9 HIS A 78 ARG A 80 1 N TRP A 79 O LYS A 167 SHEET 1 B 2 LEU A 117 ARG A 118 0 SHEET 2 B 2 ARG A 135 PHE A 136 -1 O ARG A 135 N ARG A 118 SHEET 1 C 4 SER B 355 TRP B 356 0 SHEET 2 C 4 GLU B 362 LYS B 364 -1 O LYS B 364 N SER B 355 SHEET 3 C 4 VAL B 411 PHE B 414 -1 O TYR B 412 N PHE B 363 SHEET 4 C 4 ILE B 402 LYS B 404 -1 N HIS B 403 O ARG B 413 SHEET 1 D 9 LEU E 62 ARG E 64 0 SHEET 2 D 9 PHE E 70 SER E 73 -1 O CYS E 72 N VAL E 63 SHEET 3 D 9 LYS E 90 ALA E 93 -1 O VAL E 92 N LEU E 71 SHEET 4 D 9 VAL E 128 ARG E 130 -1 O ALA E 129 N VAL E 91 SHEET 5 D 9 THR E 121 LYS E 125 -1 N LYS E 125 O VAL E 128 SHEET 6 D 9 LEU E 102 GLY E 108 -1 N VAL E 103 O ALA E 122 SHEET 7 D 9 PHE E 146 VAL E 152 -1 O THR E 147 N GLY E 108 SHEET 8 D 9 GLN E 158 THR E 169 -1 O ALA E 160 N ILE E 150 SHEET 9 D 9 HIS E 78 ARG E 80 1 N TRP E 79 O LYS E 167 SHEET 1 E 2 LEU E 117 ARG E 118 0 SHEET 2 E 2 ARG E 135 PHE E 136 -1 O ARG E 135 N ARG E 118 SHEET 1 F 4 SER F 355 TRP F 356 0 SHEET 2 F 4 GLU F 362 LYS F 364 -1 O LYS F 364 N SER F 355 SHEET 3 F 4 VAL F 411 PHE F 414 -1 O TYR F 412 N PHE F 363 SHEET 4 F 4 ILE F 402 LYS F 404 -1 N HIS F 403 O ARG F 413 CISPEP 1 ASN A 155 PRO A 156 0 0.04 CISPEP 2 ASN E 155 PRO E 156 0 0.10 SITE 1 AC1 3 DT C 14 DG D 103 DA D 104 CRYST1 66.153 100.032 72.064 90.00 110.23 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015116 0.000000 0.005570 0.00000 SCALE2 0.000000 0.009997 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014789 0.00000